Overview
- 12 inspections across 12 sites are on record.
- 4 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-07-02.
At a glance
Inspections
12
Sites
12
Observations
4
Career since
Nov 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Sanofi Winthrop Industrie | 2 Jul 2019 | Human Drugs | On file |
| Chiesi Farmaceutici S.p.A. | 24 May 2019 | Human Drugs | View 483 → |
| AbbVie Operations Singapore Pte. Ltd. | 5 Dec 2018 | Human Drugs | |
| Lonza Biologics, plc | 28 Sep 2018 | Human Drugs | On file |
| KBI Biopharma, Inc. | 12 Sep 2018 | Human Drugs | On file |
Sites inspected
Sanofi Winthrop IndustrieVitry Sur Seine, France1 insp.
Chiesi Farmaceutici S.p.A.Parma, Italy1 insp.
AbbVie Operations Singapore Pte. Ltd.Singapore, Singapore1 insp.
Lonza Biologics, plcSlough, United Kingdom1 insp.
KBI Biopharma, Inc.Boulder, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Steven Fong2 shared
Reyes Candau-Chacon2 shared
Saleem A Akhtar1 shared
Ralph M Bernstein1 shared
Jamie L Dion1 shared
Nicholas L Paulin1 shared
Zhong Li1 shared
Thuy T Nguyen1 shared
Michael Shanks1 shared
Kathleen R Jones1 shared
Full investigator report
Get the verbatim findings behind Scott R Nichols' 4 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site